Dx & Vx Co., Ltd. (KOSDAQ:180400)
South Korea · Delayed Price · Currency is KRW 2,310.00
+327.00 (16.49%)
At close: Jul 31, 2026
Dx & Vx Market Cap
Dx & Vx has a market cap or net worth of 227.37 billion as of July 31, 2026. Its market cap has increased by 71.73% in one year.
Market Cap
227.37B
Enterprise Value
180.23B
Revenue
28.48B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,310.00
ChartMarket Cap Chart
Since November 20, 2015, Dx & Vx's market cap has increased from 75.32B to 227.37B, an increase of 201.89%. That is a compound annual growth rate of 10.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 227.37B | 47.12% |
| Dec 30, 2025 | 154.55B | 68.91% |
| Dec 30, 2024 | 91.50B | -48.77% |
| Dec 28, 2023 | 178.59B | 52.96% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 146.07B |
| GENINUS | 72.17B |
| Cytogen | 65.17B |
| Protia | 64.01B |
| GC Medical Science | 52.07B |
| Inventera | 48.92B |
| HLB Panagene | 45.48B |
| Seoulin Bioscience | 36.22B |